NCT03732274 2025-04-10Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLCMedPacto, Inc.Phase 1/2 Completed60 enrolled
NCT05265650 2022-07-19NoeliaClinica Universidad de Navarra, Universidad de NavarraPhase 1/2 Unknown30 enrolled